Post‐exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition

British Journal of Clinical Pharmacology

Volumn 36, Issue 4, 1993, Pages 331-338

  BEAULIEU, MARC ^a   NADEAU, ANDRÉ ^a   LACOURCIÈRE, YVES ^a   CLÉROUX, JEAN ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

blood pressure; forearm vascular resistance; fosinopril; plasma noradrenaline concentrations; total peripheral resistance

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; NORADRENALIN; PLACEBO;

ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIAC OUTPUT; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FOSINOPRIL; HUMAN; HYPERTENSION; MALE; PLASMA VOLUME; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; VASCULAR RESISTANCE;

EID: 0027366160     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1993.tb00372.x     Document Type: Article

References (32)

1. Physical exercise in the management of hypertension: a consensus statement by the world hypertension league
2. Aftereffects of exercise on regional and systemic hemodynamics in hypertension
3. Blood pressure and hemodynamic responses after exercise in older hypertensives
4. Acute postexercise blood pressure response of hypertensive and normotensive men
5. Effect of exercise on recovery blood pressure in normotensive and hypertensive subjects
6. Therapeutic effect of exercise on hypertension
7. Is exercise good for high blood pressure?
8. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise
9. Postexercise reflex control of forearm vascular resistance during calcium antagonism with slow‐release oral isradipine
10. Recommendations for routine blood pressure measurements by indirect cuff sphygmomanometry
11. Exercise training‐induced hypervolemia: role of plasma albumin, renin, and vasopressin
12. Methods for the investigation of peripheral blood flow
13. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range
14. Post‐exercise reduction of blood pressure in hypertensive men is not due to acute impairment of baroreflex function
15. Postexercise hypotension and sympathoinhibition in borderline hypertensive men
16. Haemodynamic effects of ACE inhibitors
17. Hemodynamic effects of angiotensinconverting enzyme inhibitors in essential hypertension: a review
18. Effects of fosinopril on cardiac function in patients with hypertension: radionuclide assessment of left ventricular systolic and diastolic performance
19. Hemodynamic aspects of essential hypertension in humans
20. Investigation of reflexes from volume and baroreceptors during converting‐enzyme inhibition in humans
21. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man
22. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension
23. Influence of the renin‐angiotensin system on human forearm blood flow
24. Systemic and forearm vascular resistance changes after upright bicycle exercise in man
25. Baroreflex regulation of forearm vascular resistance after exercise in hypertensive and normotensive humans
26. Long‐lasting cardiovascular depressor response following sciatic stimulation in spontaneously hypertensive rats: Evidence for the involvement of central endorphin and serotonin systems
27. Norepinephrine removal and release in the forearm of healthy subjects
28. Angiotensin II facilitates sympathetic transmission in rat hind limb circulation
29. Interaction between sympathetic and renin‐angiotensin system
30. Renin‐ and non‐renin‐mediated antihypertensive actions of converting enzyme inhibitors